help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 22, 2006, doi:10.1164/rccm.200601-054OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200601-054OCv1
175/4/336    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trujillo-Vargas, C. M.
Right arrow Articles by Erb, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trujillo-Vargas, C. M.
Right arrow Articles by Erb, K. J.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 336-344, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200601-054OC


Original Article

Helminth-derived Products Inhibit the Development of Allergic Responses in Mice

Claudia M. Trujillo-Vargas1,2, Melanie Werner-Klein3, Gisela Wohlleben1, Tobias Polte4, Gesine Hansen4, Stefan Ehlers5 and Klaus J. Erb1,3

1 Center for Infectious Diseases, University of Würzburg, Würzburg, Germany; 2 Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia, Medellín, Colombia; 3 Department of Pulmonary Research, Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riss, Germany; 4 Division of Allergy and Pulmonology, Department of Pediatrics, Martin-Luther-University, Halle-Wittenberg, Halle, Germany; and 5 Molecular Infection Biology, Research Center Borstel, Leibniz Center for Medicine and Biosciences, Borstel, Germany

Correspondence and requests for reprints should be addressed to Dr. Klaus Erb, Ph.D., Department of Pulmonary Research, Boehringer-Ingelheim Pharma GmbH & Co. KG, H91-02-01, Birkendorferstr. 65, D-88397 Biberach a.d. Riss, Germany. E-mail: klaus.erb{at}bc.boehringer-ingelheim.com

Rationale: Epidemiological studies suggest that infections with helminths protect from the development of asthma. Supporting this view is our published finding that infection with Nippostrongylus brasiliensis decreased ovalbumin-induced Th2 responses in the lung of mice.

Objectives: To evaluate if N. brasiliensis excretory–secretory products also prevent the development of asthma.

Methods: Mice were immunized with ovalbumin/alum intraperitoneally in the absence or presence of helminthic products and then challenged intranasally with ovalbumin. Six days later, we analyzed if the mice developed Th2 responses in the lung.

Main Results: The application of the helminthic products together with ovalbumin/alum during the sensitization period totally inhibited the development of eosinophilia and goblet cell metaplasia in the airways and also strongly reduced the development of airway hyperreactivity. Allergen-specific IgG1 and IgE serum levels were also strongly reduced. These findings correlated with decreased levels of IL-4 and IL-5 in the airways in product-treated animals. The suppressive effects on the development of allergic responses were independent of the presence of Toll-like receptors 2 and 4, IFN-{gamma}, and most important, IL-10. Interestingly, suppression was still observed when the helminthic products were heated or treated with proteinase K. Paradoxically, we found that strong helminth product–specific Th2 responses were induced in parallel with the inhibition of ovalbumin-specific responses.

Conclusion: Our results suggest that helminths suppress the development of asthma by secreting substances that modulate allergic responses without affecting the generation of helminth-specific Th2 immunity. The identification of these products may lead to the design of novel therapeutic intervention strategies for the treatment of asthma.

Key Words: allergy • helminth • Nippostrongylus brasiliensis • products • inhibition


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Epidemiological studies and animal work support the hypothesis that infections with helminths protect from the development of allergic responses.

What This Study Adds to the Field
Helminths may suppress the development of asthma by producing substances that interfere selectively with the induction of allergen- but not helminth-specific Th2 responses.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1068 - 1073.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. Schnoeller, S. Rausch, S. Pillai, A. Avagyan, B. M. Wittig, C. Loddenkemper, A. Hamann, E. Hamelmann, R. Lucius, and S. Hartmann
A Helminth Immunomodulator Reduces Allergic and Inflammatory Responses by Induction of IL-10-Producing Macrophages
J. Immunol., March 15, 2008; 180(6): 4265 - 4272.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008